Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7233416rdf:typepubmed:Citationlld:pubmed
pubmed-article:7233416lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:7233416lifeskim:mentionsumls-concept:C0002006lld:lifeskim
pubmed-article:7233416lifeskim:mentionsumls-concept:C0010124lld:lifeskim
pubmed-article:7233416lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:7233416lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:7233416lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:7233416lifeskim:mentionsumls-concept:C1457869lld:lifeskim
pubmed-article:7233416lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:7233416pubmed:issue2lld:pubmed
pubmed-article:7233416pubmed:dateCreated1981-7-23lld:pubmed
pubmed-article:7233416pubmed:abstractTextHLA phenotypes were studied in nine Jewish families, originating from Iran, with 18 individuals affected with a selective aldosterone biosynthetic defect and 12 healthy siblings. This disorder is inherited through an autosomal recessive gene and parents were consanguineously related in eight out of nine sibships. Family analysis showed that 18 affected individuals carried 20 different haplotypes and only two patients were homozygous for a haplotype. Yet a peak lod score of 1.128 was obtained for the recombinant fraction of 0.05 and thus linkage to HLA cannot be ruled out.lld:pubmed
pubmed-article:7233416pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:languageenglld:pubmed
pubmed-article:7233416pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:citationSubsetIMlld:pubmed
pubmed-article:7233416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7233416pubmed:statusMEDLINElld:pubmed
pubmed-article:7233416pubmed:monthFeblld:pubmed
pubmed-article:7233416pubmed:issn0001-2815lld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:DupontBBlld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:SackJJlld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:TheodorRRlld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:CohenTTlld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:BrautbarCClld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:LevineL SLSlld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:SharonRRlld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:RöslerAAlld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:LeveneCClld:pubmed
pubmed-article:7233416pubmed:authorpubmed-author:SmallerSSlld:pubmed
pubmed-article:7233416pubmed:issnTypePrintlld:pubmed
pubmed-article:7233416pubmed:volume17lld:pubmed
pubmed-article:7233416pubmed:ownerNLMlld:pubmed
pubmed-article:7233416pubmed:authorsCompleteYlld:pubmed
pubmed-article:7233416pubmed:pagination212-6lld:pubmed
pubmed-article:7233416pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:meshHeadingpubmed-meshheading:7233416-...lld:pubmed
pubmed-article:7233416pubmed:year1981lld:pubmed
pubmed-article:7233416pubmed:articleTitleHLA in a selective aldosterone biosynthetic defect due to type 2 corticosterone methyl-oxidase deficiency.lld:pubmed
pubmed-article:7233416pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7233416pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7233416pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed